Tag: Investing
-
Enveric posts $9.5M loss for 2024, but revenue could be on horizon with licensing deals
Florida-based psychedelics firm Enveric Biosciences (NASDAQ: ENVB), which is still in the pre-revenue stage, this week reported a $9.5 million net loss for 2024, down from the $17.4 million it lost in 2023 but still well in the red as it continues developing non-hallucinatory treatments for mental health disorders. The …
-
CanadaBis Capital posts sales growth ahead of Simply Solventless deal
CanadaBis Capital Inc. (TSXV: CANN) reported revenue of C$4.9 million for its second quarter of its fiscal 2025, up from C$4.3 million versus the same period last year, but the company saw a slight decline in net income for the period. The cannabis producer and processor posted net income of …
-
Grown Rogue nabs $7M credit line from FDIC-insured bank
Oregon-based craft cannabis producer Grown Rogue International (CSE: GRIN) (OTC: GRUSF) said it secured a $7 million credit facility from a “national, FDIC-insured commercial bank.” The four-year credit facility carries an interest rate of around 9.2% per annum, calculated as the secured overnight financing rate (SOFR) – which is currently …